Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
804.2 GBX | 0.00% | 0.00% | 0.00% |
May. 14 | DB and Berenberg raise Diploma price target | AN |
May. 09 | European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.99 for the current year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 27.32B | - | ||
+13.16% | 79.54B | B- | ||
+10.65% | 52.13B | B+ | ||
+5.43% | 49.04B | B | ||
+21.55% | 46.7B | B+ | ||
+14.84% | 42.69B | B+ | ||
+28.76% | 41.44B | B | ||
+0.57% | 29.51B | B | ||
-3.53% | 29.11B | B- | ||
+23.72% | 24.62B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PRU Stock
- PRU Stock
- Ratings Prudential plc